Abstract Details
|
Ran Liu, MD
(Markham Stouffville Hospital)
PRESENTER |
Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Knight Therapeutics. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Liu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Liu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia. Dr. Liu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Liu has received research support from Knight Therapeutics. |
| Erum M. Shariff, MBBS, FCPS (King Fahd Hospital. Imam AbdulRahman bin Faisal University) | Dr. Shariff has nothing to disclose. |